New

ETF model portfolios designed for real investor needs. Discover →

Advertisement
Advertisement
PSCH
US Health Care
Passive

Invesco S&P SmallCap Health Care ETF

This ETF provides exposure to Small Cap US Health Care Equities

PSCH performance and flow charts

Last update 9/10/2026 at 1:30 PM
Live
Closed
Last price
$53.11
-$0.60 (-1.12%) Today

Performance

-3.0-2.0-1.00.01.0%Aug 10Aug 17Aug 24Aug 31Sep 8

Flows

0 M5 M10 M15 M
1 day price range
$53.08
$53.55
52 week price range
$39.20
$56.12
1W perf
-2.16%
YTD perf
+21.86%
YTD flows
+$7M
AuM
$182M
E/R
0.29%
TTM yield
0%
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of September 9, 2026
1M3MYTD1Y3Y5Y
Perf.-2.89%+13.44%+21.86%+30.10%+36.07%-13.90%
Flows+$14M+$25M+$7M+$2M-$109M-$207M
Data as of September 9, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

The Invesco S&P SmallCap Health Care ETF is built to track the S&P SmallCap 600 Capped Health Care Total Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.

Management strategyPassive
StrategyLong Only
ProviderInvesco
N° of holdings69
Replication methodDirect (Physical)
Asset classEquity
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateApril 7, 2010
ESGNo
TrackinsightTrackinsight

More data and info about PSCH on Trackinsight

Exposure

Data as of July 31, 2026

Diversification

48.1%

Total weight of top 15 holdings out of 69

Top 15 Holdings

Glaukos Corp.
4.96%
Corcept Therapeutics, Inc.
4.64%
Alkermes Plc
4.21%
Protagonist Therapeutics, Inc.
4.2%
TG Therapeutics, Inc.
3.68%
PTC Therapeutics, Inc.
3.23%
Liquidia Corp.
3.19%
Teleflex, Inc.
3.11%
Ligand Pharmaceuticals, Inc.
3.01%
Indivior Pharmaceuticals, Inc.
2.55%
Merit Medical Systems, Inc.
2.52%
RadNet, Inc.
2.34%
Veracyte, Inc.
2.32%
ICU Medical, Inc.
2.17%
Concentra Group Holdings Parent, Inc.
1.96%

Sectors

Healthcare
100%
Other
0%

Countries

USA
95.04%
Other
4.96%
Advertisement

Trading data

Last sale
9/10/2026 at 1:30 PM
$53.11
Previous close
$53.71
Consolidated volume
09/09/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+15.73%+19.67%+21.83%+22.87%
Max drawdown
-4.27%-15.36%-22.80%-45.76%
Max drawdown duration
21d168d488d1766d
Time to recover
N/A71d321dN/A

Replication quality

Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free
Tracking error
Join for free
Tracking difference
Join for free
1 year cumulative return difference
Best
Join for free
Worst
Join for free
daily return difference
Average
Join for free
Worst
Join for free
Frequently asked questions about PSCH

What type of ETF is PSCH?

PSCH is a Passive ETF that provides exposure to Equity assets. It is managed by Invesco.

What index does PSCH track?

PSCH tracks the S&P SmallCap 600 Capped Health Care Total Return Index - USD, aiming to replicate its performance through full replication.

What does PSCH invest in?

This ETF provides exposure to Small Cap US Health Care Equities. It is part of the segment: US Health Care.

What is the expense ratio of PSCH?

The total expense ratio (TER) of PSCH is 0.29%, representing the annual fee charged by the fund manager.

When was PSCH launched?

PSCH was launched on April 7, 2010, marking its entry into the ETF market.

Who is the issuer of PSCH?

PSCH is issued by Invesco.

What is the AUM of PSCH?

As of September 9, 2026, PSCH manages $181.59 M, reflecting the total assets held in the fund.

How has PSCH performed recently?

As of September 9, 2026, PSCH delivered a return of -2.89% over the past month (1M performance), 13.44% over the past three months (3M), and 21.86% year-to-date (YTD).

What are the recent fund flows for PSCH?

As of September 9, 2026, PSCH has seen net flows of +$14M in the past month (1M flow) and +$7M year-to-date (YTD).

Does PSCH pay dividends?

As of September 9, 2026, PSCH has a trailing 12-month distribution yield of 0%.

How many holdings are in PSCH

As of July 31, 2026, PSCH holds 69 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is PSCH?

As of July 31, 2026, PSCH holds 69 securities, with 48.1% of its assets concentrated in its top 15 holdings.

What are the top holdings of PSCH?

As of July 31, 2026, PSCH holds a portfolio of 69 underlyings, with its largest positions including Glaukos Corp., Corcept Therapeutics, Inc. and Alkermes Plc. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does PSCH invest in?

As of July 31, 2026, PSCH has its largest geographic exposures in USA.

What sectors or themes does PSCH focus on?

As of July 31, 2026, PSCH is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides

Recent educational content

Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 8, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 9, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 31, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 1, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 24, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · August 24, 2026
What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

What’sTheFund

What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

James St Aubin, Chief Investment Officer at Ocean Park Asset Management, discuss the DUKZ ETF, exposing investors to the whole spectrum of asset classes in the fixed income markets, through their rules-based process.

NYSE logo
By NYSE · August 18, 2026

Browse all educational columns

Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder